Technical Analysis for KARBF - Karo Pharma Aktiebolag

Grade Last Price % Change Price Change
grade B 4.25 -3.85% -0.1700
KARBF closed down 3.85 percent on Tuesday, July 2, 2019, on 4 percent of normal volume.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent N/A N/A N/A
See historical KARBF trend table...

Date Alert Name Type % Chg
Hot IPO Pullback Bullish Swing Setup 0.00%
Narrow Range Bar Range Contraction 0.00%
Gapped Down Weakness 0.00%
Narrow Range Bar Range Contraction -3.85%
New 52 Week Closing High Bullish -3.85%
Narrow Range Bar Range Contraction -3.85%
New 52 Week High Strength -3.85%
Gapped Up Strength -3.85%

Older signals for KARBF ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Karo Pharma AB (publ), a healthcare company, develops and markets products for pharmacies and the health care sectors in Sweden, Norway, Denmark, and Finland. The company's development projects are focused on nuclear receptors as target proteins for the development of pharmaceuticals. Its products include Mabs medical compression socks to enhance blood circulation in the legs; Allévo nutritional products; Swereco ergonomic products for people with disabilities; and Dosett medicine storage products. The company also offers Triolif, an over-the-counter medicine for the treatment of sore throats; Vagisan, an over-the-counter product for the treatment of vaginal dryness for women; Plantur 39 for the treatment of hair; Slicks stockings and tights for legs; and BabySlide, a product to reduce lacerations during childbirth, as well as medicines for the treatment of pains, such as headache, toothache, menstrual pain, muscle pain, and joint pain. Its products under development include nuclear receptor RORgamma based products for the treatment of autoimmune diseases; compounds to treat multiple sclerosis and cancer; and T268A, a common cold spray. Karo Pharma AB (publ) markets and distributes its products through the retail market, health specialist stores, and convenience stores. The company was formerly known as Karo Bio AB (publ) and changed its name to Karo Pharma AB (publ) in March 2016. Karo Pharma AB (publ) was founded in 1987 and is headquartered in Stockholm, Sweden.
Healthcare Cancer Pharmaceuticals Pharmaceutical Industry In China Pain Pharmaceuticals Policy Autoimmune Diseases Science And Technology In The People's Republic Of China Nutritional Products Multiple Sclerosis Headache Joint Pain Pharmacy In China Retail Market Treatment Of Autoimmune Diseases Pains Muscle Pain Sore Throats
Is KARBF a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 1 bullish, 0 bearish and 4 neutral indicators. You may wish to incorporate that into your trading strategies.
Recent News
Indicator Value
52 Week High 4.42
52 Week Low 3.95
Average Volume 2,472
200-Day Moving Average 0.0
50-Day Moving Average 0.0
20-Day Moving Average 0.0
10-Day Moving Average 0.0
Average True Range 0.0
ADX 0.0
+DI 0.0
-DI 0.0
Chandelier Exit (Long, 3 ATRs ) N/A
Chandelier Exit (Short, 3 ATRs ) N/A
Upper Bollinger Band 0.0
Lower Bollinger Band 0.0
Percent B (%b) 0.0
BandWidth 0.0
MACD Line 0.0
MACD Signal Line 0.0
MACD Histogram 0.0
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 4.2500
Resistance 3 (R3) 4.2500 4.2500 4.2500
Resistance 2 (R2) 4.2500 4.2500 4.2500 4.2500
Resistance 1 (R1) 4.2500 4.2500 4.2500 4.2500 4.2500
Pivot Point 4.2500 4.2500 4.2500 4.2500 4.2500
Support 1 (S1) 4.2500 4.2500 4.2500 4.2500 4.2500
Support 2 (S2) 4.2500 4.2500 4.2500 4.2500
Support 3 (S3) 4.2500 4.2500 4.2500
Support 4 (S4) 4.2500